Home › Funds › Versant Venture Management, LLC › IPSC
Versant Venture Management, LLC position in IPSC
Century Therapeutics, Inc. · Health Care
Versant Venture Management, LLC reported holding 12,166,109 shares of IPSC (Century Therapeutics, Inc.) in its Q3 2026 13F filing — a position valued at US$20.8M, representing 19.07% of its reported portfolio and ranking #2 among its reported holdings. Versant Venture Management, LLC has disclosed IPSC holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Versant Venture Management, LLC's IPSC position evolved
Versant Venture Management, LLC first disclosed a stake in IPSC in Q1 2026 at 12,166,109 shares (US$27.5M). The position peaked in Q2 2026 at 12,166,109 shares, worth US$29.8M. Across 3 filings, Versant Venture Management, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 12,166,109 shares valued at US$20.8M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 12.17M | $27.50M | New |
| Q2 2026 | 12.17M | $29.81M | Hold |
| Q3 2026 | 12.17M | $20.80M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IPSC and 13F data
IPSC (Century Therapeutics, Inc.) is a Health Care company. 48 other funds we track also report a position in IPSC — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$43.5M), TCG Crossover Management, LLC (US$43.4M), Commodore Capital LP (US$21.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IPSC
- RA CAPITAL MANAGEMENT, L.P. 17.75M sh · $43.50M · Q2 2026
- TCG Crossover Management, LLC 17.75M sh · $43.40M · Q2 2026
- Commodore Capital LP 8.70M sh · $21.30M · Q2 2026
- Venrock Adviser, LLC 8.70M sh · $21.30M · Q2 2026
- Seven Fleet Capital Management LP 4.35M sh · $10.65M · Q2 2026
- Trails Edge Capital Partners, LP 4.13M sh · $10.13M · Q2 2026
- Spruce Street Capital LP 4.06M sh · $6.94M · Q3 2026
- DAFNA Capital Management LLC 2.40M sh · $5.88M · Q2 2026
- STEMPOINT CAPITAL LP 2.15M sh · $5.26M · Q2 2026
- DV Trading LLC 1.40M sh · $3.43M · Q2 2026
- Casdin Capital 1.23M sh · $3.01M · Q2 2026
More on Versant Venture Management, LLC
FAQ
How long has Versant Venture Management, LLC held IPSC?
Versant Venture Management, LLC has disclosed IPSC holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Versant Venture Management, LLC's current position in IPSC?
As of Q3 2026, Versant Venture Management, LLC holds 12.17M shares of IPSC (Century Therapeutics, Inc.), valued at $20.80M, representing 19.07% of its reported portfolio and ranking #2.
Has Versant Venture Management, LLC been buying or selling IPSC?
In the latest 13F filing (Q3 2026), Versant Venture Management, LLC held unchanged its position in IPSC. The position peaked in Q2 2026 at 12.17M shares.
Which other funds hold IPSC?
Other major institutional holders of IPSC include RA CAPITAL MANAGEMENT, L.P., TCG Crossover Management, LLC, Commodore Capital LP, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.